摘要
患者1,男性,85岁,因下咽癌3年余,颈部包块增大4月,皮肤破溃3月。”于2008年11月20日入院,入院诊断:(1)下咽癌放疗后,右颈部淋巴结转移;(2)肺栓塞,呼吸衰竭;(3)慢性支气管炎,慢性阻塞性肺气肿;(4)冠心病,
出处
《中国医院药学杂志》
CAS
CSCD
北大核心
2011年第20期1744-1745,共2页
Chinese Journal of Hospital Pharmacy
参考文献7
-
1邓雪娥.利奈唑胺[J].中国新药杂志,2001,10(11):864-866. 被引量:9
-
2Attassi K, Hershberger E, Alam R, et al. Thrombocytopenia associated with linezolid therapy[J]. Clin Infect Dis, 2002, 34 (5): 695 -698.
-
3Garazzino S, De Rosa FG, Bargiacchi O, et al. Haematological safety o{ long term therapy with linezolid[J].Int J Antimierob Agents,2007, 29(4): 480 -483.
-
4Lin YH, Wu VC, Tsai IJ, et al. High frequency of linezolid associated thrombocytopenia among patients with renal insufficiency[J]. Int J Antimicrob Agents,2006,28(4):345-351.
-
5Attassi K, Hershberger E, Alam R, et al. Thromboeytopenia associated with linezolid therapy[J].Clin Infect Dis, 2002,34 (5) :695-698.
-
6邹琳,刘长庭.利奈唑胺在高龄老年患者中的临床应用[J].中华医院感染学杂志,2010,20(3):399-401. 被引量:22
-
7Bernstein WB, Trotta RF, Rector JT, et al. Mechanisms for linezolid induced anemia and thrombocytopenia[J].Ann Phar macother,2003,37(4) :517 -520.
二级参考文献9
-
1裴斐,王睿.磷霉素与替考拉宁对90株革兰阳性球菌的联合药敏研究[J].中华医院感染学杂志,2004,14(11):1282-1284. 被引量:11
-
2Hayden MK. Insights into the epidemiology and control of infection with vancomycin-resistant enterococci[J]. Clin Infect Dis,2001,31(4) :1058-1065.
-
3Kohno S, Yamaguchi K, Aikawa N. Linezolid versus vanco mycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan [J]. J Antimicrob Chemother, 2007,60(6) : 1361-1369.
-
4Lin DF,Zhang YY,Wu JF. Linezolid for the treatment of infections caused by Gram-positive pathogens in China[J]. Int J Antimicrob Agents, 2008,32 (3): 241-249.
-
5Wilcox M, Nathwani D. Dryden M. Linezolid compared with teicoplanin for the treatment of suspected or proven Grampositive infections[J]. J Antimicrob Chemother,2004,53(2) : 335-344.
-
6[1]Diekema DJ, Jones RN. Oxazolidinones[J]. Drugs, 2000,59(1):7-16.
-
7刘坤,李有信,杜晓玲.耐万古霉素肠球菌医院感染危险因素分析[J].中华医院感染学杂志,2007,17(8):1000-1002. 被引量:17
-
8肖永红,王进,赵彩云,高磊,郑波,薛峰,李湘艳,郝凤兰,代表Mohnarin协作组.2006-2007年Mohnarin细菌耐药监测[J].中华医院感染学杂志,2008,18(8):1051-1056. 被引量:607
-
9汪复.抗菌药物临床应用进展[J].中国抗感染化疗杂志,2002,2(2):115-119. 被引量:39
共引文献29
-
1褚燕琦,王春梅,罗晓媛,李学锋.对1例骨折截肢术后老年患者使用利奈唑胺的药物监测[J].中国药物应用与监测,2010,7(4):232-234. 被引量:3
-
2孙玉蓉,张萍.静脉输注利奈唑胺注射液的病情观察与护理[J].护士进修杂志,2011,26(6):568-569. 被引量:1
-
3王博雅,闫素英.利奈唑胺的不良反应及合理应用[J].药物流行病学杂志,2011,20(8):434-437. 被引量:14
-
4周叶.利奈唑胺致老年患者血小板降低3例报告[J].浙江实用医学,2011,16(6):461-462. 被引量:3
-
5包旻,姜玲,孙言才,史天陆,杨昭毅,魏伟.某“三甲”医院利奈唑胺注射剂临床应用合理性评价[J].中国药房,2012,23(10):881-883. 被引量:7
-
6李娟,马容莉,张艳.利奈唑胺治疗老年肺部感染对血小板的影响[J].医药导报,2012,31(3):312-315. 被引量:3
-
7王虎军,毕磊,刘静,杨永革.利奈唑胺对老年人医院获得性MRSA肺炎的疗效观察[J].浙江临床医学,2012,14(10):1192-1194. 被引量:4
-
8夏鸿剑,刘维波,蔡雅卫,朱瑶.利奈唑胺针剂与片剂交替治疗高龄重症感染患者的疗效观察[J].浙江医学,2012,34(24):1995-1997.
-
9安儒峰,王立兰.利奈唑胺相关性血小板减少症[J].中国新药杂志,2013,22(12):1469-1472. 被引量:7
-
10张莉,孟现民,张永信.利奈唑胺的药理学特点及临床应用[J].上海医药,2013,34(13):8-11. 被引量:9
同被引文献19
-
1周践,周筱青.65例亚胺培南/西司他丁药品不良反应分析[J].中华医院感染学杂志,2004,14(6):671-673. 被引量:19
-
2冯祚臻,官东秀.亚胺培南/西司他丁不良反应57例文献分析[J].中国药业,2006,15(16):39-39. 被引量:13
-
3McGhan RM.Clinical respiratory medicine(third edition):corticosteroids[M].Philadelphia, Mosby:Academic Press,2003:483 -489.
-
4Marinho DS,Huf G,Ferreira BL,et al.The study of vancomycin use and its adverse reactions associated to patients of a Brazilian university hospital[J].BMC Res notes,2011,4(1):236.
-
5Wood MJ. Comparative safety ofteicop lanin and vancomycin [J]. J Chemother,2000,12 (Supp 15):21-251.
-
6Svetitsky S,Leibovici L,Paul M.Comparative efficacy and safety of vaneomycin versus teicoplanin:systematic review and meta- analysis[J]. Antimicrob Agents Chemother,2009, 53(10):4069.
-
7Editorial.Red man should go:vancomycin and hisfamine release[J]. Lancet, 1990,335(8696): 1006.
-
8Renz CL,Thurn JD,Finn HA,et all Antihistamine prophylaxis permmits rapid vancomycin infusion[J].Crit Care Med, 1999,27(9): 1732-1737.
-
9Espersen F, farlov J O,Jensen C,et al.Staphylococcus aureus peptidoglycan induces histamine release from basophil human leukocytes in vitro [J].Infect Immun, 1984,46:710.
-
10Renz CL,Thurn JD, Finn HA, Lynch JP, Moss J.Clinical investigations:antihistamine prophylaxis permits rapid vancomycin infusion[J].Crit Care Med, 1999, 27:1732.
-
1陈艳.维生素B4在甲亢治疗中的副作用[J].实用糖尿病杂志,2010,6(2):49-50. 被引量:1
-
2徐翠蓉,贾坤林.盐酸氨溴索治疗慢性支气管炎的临床观察[J].现代医药卫生,2009,25(13):2036-2037.
-
3冀建明,杨常成,王保平.盐酸氨溴索序贯疗法治疗慢性支气管炎的成本-效果分析[J].药学服务与研究,2010,10(6):432-434. 被引量:10
-
4姜怡雯,吴逢波,徐珽.丙硫氧嘧啶致抗中性粒细胞胞浆抗体阳性小血管炎1例[J].中国药业,2015,24(23):252-253.
-
5陈梅,金艳,袁健保,程晓霞.壳聚糖在皮肤破溃中的疗效观察[J].求医问药(下半月刊),2012,10(12).
-
6汪承松,聂俊军.临床药师对老年慢性支气管炎并发肺部感染患者的药学服务[J].医药导报,2012,31(6):808-809. 被引量:7
-
7党玲.金因肽治疗皮肤破溃56例[J].中国民间疗法,2004,12(11):51-52.
-
8邹文,李晓梅,王荣梅.阿帕替尼联合应用替吉奥致严重皮下出血及皮肤破溃1例[J].中国新药与临床杂志,2017,36(3):176-179. 被引量:15
-
9赵梁艳,廖俊辉,吴海兰.匹伐他汀钙致横纹肌溶解1例[J].中国药物警戒,2014,11(10):635-635. 被引量:1
-
10赵娜.静滴注射用头孢匹胺过敏一例[J].医疗装备,2008,21(11):61-61.